ArticleJournal of vascular surgery cases and innovative techniques2026
Splanchnic vein reconstruction using dedicated venous stents.
Article in Journal of vascular surgery cases and innovative techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Dedicated venous stents are designed for use in iliofemoral and thoracic central veins. This report describes the feasibility of deploying these stents in the splanchnic veins. Methods: A retrospective review of patients who underwent main portal, splenic, and/or mesenteric vein reconstruction using dedicated venous stents was performed. Technical success of stent deployment within the intended splanchnic vein(s) and clinical success of improvement in presenting symptoms of splanchnic venous obstruction were assessed. Stent patency was evaluated using contrast-enhanced computed tomography and/or Doppler ultrasound. Results: Twenty-two patients (12 men, 10 women; mean age, 56 years) were identified. The presenting symptoms included abdominal pain in 12 (55%), ascites in 11 (50%), and variceal hemorrhage in six (27%) patients. Twenty Abre Venous Stents (77%) and six Venovo Venous Stent Systems (23%) were placed in the main portal (n = 19), superior mesenteric (n = 10), and splenic (n = 8) veins. Technical success was achieved in 22 patients (100%). Clinical success was achieved in 17 patients (77%). Follow-up imaging was obtained in 19 patients (86%). The latest available studies occurred at a median of 110 days (range, 7-1091 days; interquartile range, 38-427 days) from the index procedures and demonstrated an estimated 1-year primary stent patency rate of 83% (95% confidence interval, 57%-94%). Conclusions: The use of dedicated venous stents in splanchnic vein reconstruction is feasible with a high technical success rate, favorable clinical outcomes, and promising short-term patency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.